Rochester,NY 8/27/2009 10:22:41 PM
American Bio Medica Corp. ABMC, Reports Operating Results (10-Q)
American Bio Medica Corp.
American Bio Medica Corp. (ABMC) filed Quarterly Report for the period ended 2009-06-30.
During the six months ended June 30, 2009, the Company sustained a net loss of $471,000 from net sales of $5,063,000. The Company had net cash provided by operating activities of $331,000 for the first six months of 2009.
The Company's contract manufacturing operations currently include the manufacture of a HIV test, a test for fetal amniotic membrane rupture, and a test for RSV (Respiratory Syncytial Virus). Contract manufacturing sales during the first half of 2009 totaled $132,000, down from $271,000 in the same period a year ago. This decrease is primarily the result of declines in sales of the RSV product and the fetal amniotic membrane rupture test, which were offset by increases in sales of the HIV test.
Contract manufacturing sales during the second quarter of 2009 totaled $38,000, down from $139,000 in the same period a year ago. This decrease is the result of declines in sales of the RSV product and the fetal amniotic membrane rupture test.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
